MeSH Review:
Tanacetum parthenium
Modi,
Lowder,
Diener,
Pfaffenrath,
Schnitker,
Friede,
Henneicke-von Zepelin,
Pfaffenrath,
Diener,
Fischer,
Friede,
Henneicke-von Zepelin,
Khan,
Abourashed,
Khan,
Walker,
Wargovich,
Woods,
Hollis,
Zander,
Piela-Smith,
Liu,
Li-Weber,
Giaisi,
Baumann,
Treiber,
Krammer,
Fonseca,
Rushing,
Rajapakse,
Thomas,
Riley,
Smolinski,
Pestka,
- Nuclear factor-kappaB as a molecular target for migraine therapy. Reuter, U., Chiarugi, A., Bolay, H., Moskowitz, M.A. Ann. Neurol. (2002)
- Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Patel, N.M., Nozaki, S., Shortle, N.H., Bhat-Nakshatri, P., Newton, T.R., Rice, S., Gelfanov, V., Boswell, S.H., Goulet, R.J., Sledge, G.W., Nakshatri, H. Oncogene (2000)
- Parthenolide and abscisic acid synthesis in feverfew are associated but environmental factors affect them dissimilarly. Fonseca, J.M., Rushing, J.W., Rajapakse, N.C., Thomas, R.L., Riley, M.B. J. Plant Physiol. (2005)
- Do monoterpenes released from feverfew (Tanacetum parthenium) plants cause airborne Compositae dermatitis? Paulsen, E., Christensen, L.P., Andersen, K.E. Contact Derm. (2002)
- Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Heptinstall, S., White, A., Williamson, L., Mitchell, J.R. Lancet (1985)
- Extract of feverfew inhibits prostaglandin biosynthesis. Collier, H.O., Butt, N.M., McDonald-Gibson, W.J., Saeed, S.A. Lancet (1980)
- The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cells. Li-Weber, M., Giaisi, M., Baumann, S., Treiber, M.K., Krammer, P.H. Cell Death Differ. (2002)
- The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Kwok, B.H., Koh, B., Ndubuisi, M.I., Elofsson, M., Crews, C.M. Chem. Biol. (2001)
- Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Diener, H.C., Pfaffenrath, V., Schnitker, J., Friede, M., Henneicke-von Zepelin, H.H. Cephalalgia : an international journal of headache. (2005)
- Medications for migraine prophylaxis. Modi, S., Lowder, D.M. American family physician. (2006)
- Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver. Smolinski, A.T., Pestka, J.J. Journal of inflammation (London, England) (2005)
- The activity of compounds extracted from feverfew on histamine release from rat mast cells. Hayes, N.A., Foreman, J.C. J. Pharm. Pharmacol. (1987)
- The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Pfaffenrath, V., Diener, H.C., Fischer, M., Friede, M., Henneicke-von Zepelin, H.H. Cephalalgia : an international journal of headache. (2002)
- Herbals, cancer prevention and health. Wargovich, M.J., Woods, C., Hollis, D.M., Zander, M.E. J. Nutr. (2001)
- The effect of an aqueous extract of Tanacetum parthenium L. on arachidonic acid metabolism by rat peritoneal leucocytes. Capasso, F. J. Pharm. Pharmacol. (1986)
- Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts. Piela-Smith, T.H., Liu, X. Cell. Immunol. (2001)
- 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content. Mittra, S., Datta, A., Singh, S.K., Singh, A. Acta Pharmacol. Sin. (2000)
- Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Pattrick, M., Heptinstall, S., Doherty, M. Ann. Rheum. Dis. (1989)
- Immediate hypersensitivity to Parthenium hysterophorus. II. Clinical studies on the prevalence of Parthenium rhinitis. Sriramarao, P., Nagpal, S., Rao, B.S., Prakash, O., Rao, P.V. Clin. Exp. Allergy (1991)
- Transport of parthenolide across human intestinal cells (Caco-2). Khan, S.I., Abourashed, E.A., Khan, I.A., Walker, L.A. Planta Med. (2003)
- Compositae dermatitis in a Danish dermatology department in one year (I). Results of routine patch testing with the sesquiterpene lactone mix supplemented with aimed patch testing with extracts and sesquiterpene lactones of Compositae plants. Paulsen, E., Andersen, K.E., Hausen, B.M. Contact Derm. (1993)
- Parthenolide inhibits the contractile responses of rat stomach fundus to fenfluramine and dextroamphetamine but not serotonin. Béjar, E. Journal of ethnopharmacology. (1996)